speb/financial-data huggingface dataset:
SIBN balance_sheet (quarterly, 2025-09-30) — Share Issued: 43273382.00
SIBN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6226000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 172126000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 172126000.00
SIBN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SIBN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Assets: 234273000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 207666000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Debt: 36836000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 172126000.00
SIBN income_statement (quarterly, 2025-09-30) — Total Expenses: 54039000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 62147000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 23489000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 35705000.00
SIBN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -5383000.00
SIBN balance_sheet (quarterly, 2025-09-30) — Working Capital: 184342000.00
SIBN income_statement (annual, 2025-12-31) — +Operating Expense: 182209000.00
SIBN income_statement (quarterly, 2025-12-31) — +Operating Expense: 46994000.00
SIBN income_statement (annual, 2025-12-31) — +Total Revenue: 200925000.00
SIBN income_statement (quarterly, 2025-12-31) — +Total Revenue: 56349000.00
SIBN balance_sheet (annual, 2025-12-31) — Accounts Payable: 4631000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4631000.00
SIBN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 29915000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 29915000.00
SIBN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -22547000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -22547000.00
SIBN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 626970000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 626970000.00
SIBN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1013000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1013000.00
SIBN cash_flow (annual, 2025-12-31) — Amortization Of Securities: -3051000.00
SIBN cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -611000.00
SIBN income_statement (annual, 2025-12-31) — Basic Average Shares: 42959856.00
SIBN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 43507786.00
SIBN income_statement (annual, 2025-12-31) — Basic EPS: -0.44
SIBN income_statement (quarterly, 2025-12-31) — Basic EPS: -0.04
SIBN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 34948000.00
SIBN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 26487000.00
SIBN cash_flow (annual, 2025-12-31) — Capital Expenditure: -8414000.00
SIBN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1288000.00
SIBN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1119000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1119000.00
SIBN balance_sheet (annual, 2025-12-31) — Capital Stock: 4000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4000.00
SIBN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 42240000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 42240000.00
SIBN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 147823000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 147823000.00
SIBN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3376000.00
SIBN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1029000.00
SIBN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 4160000.00
SIBN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 13026000.00
SIBN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -675000.00
SIBN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1728000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Account Payable: -1763000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -3008000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 179000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 2106000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Inventory: -8684000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Inventory: 1650000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Payable: -1763000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Payable: -3008000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1584000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -902000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1030000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1449000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Receivables: -3027000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -3391000.00
SIBN cash_flow (annual, 2025-12-31) — Change In Working Capital: -14325000.00
SIBN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -4092000.00
SIBN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3027000.00
SIBN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -3391000.00
SIBN cash_flow (annual, 2025-12-31) — Changes In Cash: 6861000.00
SIBN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 15783000.00
SIBN balance_sheet (annual, 2025-12-31) — Common Stock: 4000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Common Stock: 4000.00
SIBN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 177532000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 177532000.00
SIBN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
SIBN balance_sheet (annual, 2025-12-31) — Construction In Progress: 5901000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 5901000.00
SIBN income_statement (annual, 2025-12-31) — Cost Of Revenue: 41046000.00
SIBN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11818000.00
SIBN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4923000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4923000.00
SIBN balance_sheet (annual, 2025-12-31) — Current Assets: 216115000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Current Assets: 216115000.00
SIBN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 944000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 944000.00
SIBN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 944000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 944000.00
SIBN balance_sheet (annual, 2025-12-31) — Current Liabilities: 25279000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 25279000.00
SIBN cash_flow (annual, 2025-12-31) — Depreciation: 5800000.00
SIBN cash_flow (quarterly, 2025-12-31) — Depreciation: 1700000.00
SIBN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5770000.00
SIBN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1638000.00
SIBN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5770000.00
SIBN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1638000.00
SIBN income_statement (annual, 2025-12-31) — Diluted Average Shares: 42959856.00
SIBN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 43507786.00
SIBN income_statement (annual, 2025-12-31) — Diluted EPS: -0.44
SIBN income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.04
SIBN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1644000.00
SIBN income_statement (annual, 2025-12-31) — EBIT: -16276000.00
SIBN income_statement (quarterly, 2025-12-31) — EBIT: -1014000.00
SIBN income_statement (annual, 2025-12-31) — EBITDA: -10506000.00
SIBN income_statement (quarterly, 2025-12-31) — EBITDA: 624000.00
SIBN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 431000.00
SIBN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -30000.00
SIBN cash_flow (annual, 2025-12-31) — End Cash Position: 42240000.00
SIBN cash_flow (quarterly, 2025-12-31) — End Cash Position: 42240000.00
SIBN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 3376000.00
SIBN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1029000.00
SIBN balance_sheet (annual, 2025-12-31) — Finished Goods: 29900000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 29900000.00
SIBN cash_flow (annual, 2025-12-31) — Free Cash Flow: -9089000.00
SIBN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 440000.00
SIBN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 1627000.00
SIBN cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 185000.00
SIBN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 816000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 816000.00
SIBN income_statement (annual, 2025-12-31) — General And Administrative Expense: 40537000.00
SIBN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 9825000.00
SIBN balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 30928000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 30928000.00
SIBN balance_sheet (annual, 2025-12-31) — Gross PPE: 44932000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 44932000.00
SIBN income_statement (annual, 2025-12-31) — Gross Profit: 159879000.00
SIBN income_statement (quarterly, 2025-12-31) — Gross Profit: 44531000.00
SIBN income_statement (annual, 2025-12-31) — Interest Expense: 2628000.00
SIBN income_statement (quarterly, 2025-12-31) — Interest Expense: 630000.00
SIBN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2628000.00
SIBN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 630000.00
SIBN income_statement (annual, 2025-12-31) — Interest Income: 6074000.00
SIBN income_statement (quarterly, 2025-12-31) — Interest Income: 1447000.00
SIBN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 6074000.00
SIBN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1447000.00
SIBN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 2533000.00
SIBN balance_sheet (annual, 2025-12-31) — Inventory: 33897000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Inventory: 33897000.00
SIBN balance_sheet (annual, 2025-12-31) — Invested Capital: 213101000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 213101000.00
SIBN cash_flow (annual, 2025-12-31) — Investing Cash Flow: 4160000.00
SIBN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 13026000.00
SIBN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
SIBN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
SIBN balance_sheet (annual, 2025-12-31) — Leases: 3873000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Leases: 3873000.00
SIBN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 175000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 175000.00
SIBN balance_sheet (annual, 2025-12-31) — Long Term Debt: 35569000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35569000.00
SIBN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 35744000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 35744000.00
SIBN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
SIBN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
SIBN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 8338000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 8338000.00
SIBN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
SIBN income_statement (annual, 2025-12-31) — Net Income: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Income: -1644000.00
SIBN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1644000.00
SIBN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1644000.00
SIBN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1644000.00
SIBN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1644000.00
SIBN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -18904000.00
SIBN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1644000.00
SIBN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1644000.00
SIBN income_statement (annual, 2025-12-31) — Net Interest Income: 3446000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Interest Income: 817000.00
SIBN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 12574000.00
SIBN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 14314000.00
SIBN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
SIBN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
SIBN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3446000.00
SIBN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 817000.00
SIBN balance_sheet (annual, 2025-12-31) — Net PPE: 22385000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Net PPE: 22385000.00
SIBN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -8414000.00
SIBN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1288000.00
SIBN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 177532000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 177532000.00
SIBN income_statement (annual, 2025-12-31) — Normalized EBITDA: -10506000.00
SIBN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 624000.00
SIBN income_statement (annual, 2025-12-31) — Normalized Income: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Normalized Income: -1644000.00
SIBN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -675000.00
SIBN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1728000.00
SIBN cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1627000.00
SIBN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 185000.00
SIBN income_statement (annual, 2025-12-31) — Operating Income: -22330000.00
SIBN income_statement (quarterly, 2025-12-31) — Operating Income: -2463000.00
SIBN income_statement (annual, 2025-12-31) — Operating Revenue: 200925000.00
SIBN income_statement (quarterly, 2025-12-31) — Operating Revenue: 56349000.00
SIBN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 43647131.00
SIBN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 43647131.00
SIBN balance_sheet (annual, 2025-12-31) — Other Current Assets: 4480000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4480000.00
SIBN balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 879000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 879000.00
SIBN income_statement (annual, 2025-12-31) — Other Gand A: 40537000.00
SIBN income_statement (quarterly, 2025-12-31) — Other Gand A: 9825000.00
SIBN income_statement (annual, 2025-12-31) — Other Income Expense: -20000.00
SIBN income_statement (quarterly, 2025-12-31) — Other Income Expense: 2000.00
SIBN balance_sheet (annual, 2025-12-31) — Other Inventories: -3000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Other Inventories: -3000.00
SIBN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 687000.00
SIBN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 62000.00
SIBN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 55000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 55000.00
SIBN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -20000.00
SIBN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 2000.00
SIBN balance_sheet (annual, 2025-12-31) — Other Properties: 26820000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Other Properties: 26820000.00
SIBN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 105583000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 105583000.00
SIBN balance_sheet (annual, 2025-12-31) — Payables: 4631000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Payables: 4631000.00
SIBN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 9554000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 9554000.00
SIBN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13902000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13902000.00
SIBN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
SIBN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
SIBN income_statement (annual, 2025-12-31) — Pretax Income: -18904000.00
SIBN income_statement (quarterly, 2025-12-31) — Pretax Income: -1644000.00
SIBN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3376000.00
SIBN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1029000.00
SIBN balance_sheet (annual, 2025-12-31) — Properties: 0.00
SIBN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SIBN cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 1997000.00
SIBN cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 213000.00
SIBN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -192526000.00
SIBN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -34686000.00
SIBN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -8414000.00
SIBN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1288000.00
SIBN balance_sheet (annual, 2025-12-31) — Receivables: 29915000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Receivables: 29915000.00
SIBN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 41046000.00
SIBN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11818000.00
SIBN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5770000.00
SIBN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1638000.00
SIBN cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
SIBN income_statement (annual, 2025-12-31) — Research And Development: 17448000.00
SIBN income_statement (quarterly, 2025-12-31) — Research And Development: 4363000.00
SIBN balance_sheet (annual, 2025-12-31) — Retained Earnings: -450258000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -450258000.00
SIBN cash_flow (annual, 2025-12-31) — Sale Of Investment: 205100000.00
SIBN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 49000000.00
SIBN income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 124224000.00
SIBN income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 32806000.00
SIBN income_statement (annual, 2025-12-31) — Selling General And Administration: 164761000.00
SIBN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 42631000.00
SIBN balance_sheet (annual, 2025-12-31) — Share Issued: 43647131.00
SIBN balance_sheet (quarterly, 2025-12-31) — Share Issued: 43647131.00
SIBN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 25524000.00
SIBN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 5977000.00
SIBN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 177532000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 177532000.00
SIBN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 177532000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 177532000.00
SIBN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SIBN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SIBN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
SIBN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
SIBN balance_sheet (annual, 2025-12-31) — Total Assets: 238555000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Assets: 238555000.00
SIBN balance_sheet (annual, 2025-12-31) — Total Capitalization: 213101000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 213101000.00
SIBN balance_sheet (annual, 2025-12-31) — Total Debt: 36688000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Debt: 36688000.00
SIBN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 177532000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 177532000.00
SIBN income_statement (annual, 2025-12-31) — Total Expenses: 223255000.00
SIBN income_statement (quarterly, 2025-12-31) — Total Expenses: 58812000.00
SIBN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 61023000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 61023000.00
SIBN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 22440000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 22440000.00
SIBN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 35744000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 35744000.00
SIBN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -22330000.00
SIBN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2463000.00
SIBN balance_sheet (annual, 2025-12-31) — Work In Process: 4000000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Work In Process: 4000000.00
SIBN balance_sheet (annual, 2025-12-31) — Working Capital: 190836000.00
SIBN balance_sheet (quarterly, 2025-12-31) — Working Capital: 190836000.00
SIBN income_statement (quarterly, 2026-03-31) — +Operating Expense: 47037000.00
SIBN income_statement (quarterly, 2026-03-31) — +Total Revenue: 52588000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6761000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 30961000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 600000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -24132000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 633029000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1062000.00
SIBN cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -564000.00
SIBN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 43959760.00
SIBN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.10
SIBN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 42240000.00
SIBN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1077000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7348000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 33535000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 144683000.00
SIBN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 34000.00
SIBN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -6232000.00
SIBN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2362000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 2098000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -5640000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Inventory: -2038000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Payable: 2098000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3542000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 777000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1142000.00
SIBN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5945000.00
SIBN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1142000.00
SIBN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -8560000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Common Stock: 4000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 178942000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 5643000.00
SIBN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10644000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5004000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Current Assets: 214720000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 658000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 658000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 21487000.00
SIBN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1617000.00
SIBN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1617000.00
SIBN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 43959760.00
SIBN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.10
SIBN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — EBIT: -3742000.00
SIBN income_statement (quarterly, 2026-03-31) — EBITDA: -2125000.00
SIBN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -145000.00
SIBN cash_flow (quarterly, 2026-03-31) — End Cash Position: 33535000.00
SIBN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 34000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 31900000.00
SIBN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -3439000.00
SIBN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 332000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 501000.00
SIBN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 10037000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 32023000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 51913000.00
SIBN income_statement (quarterly, 2026-03-31) — Gross Profit: 41944000.00
SIBN income_statement (quarterly, 2026-03-31) — Interest Expense: 592000.00
SIBN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 592000.00
SIBN income_statement (quarterly, 2026-03-31) — Interest Income: 1350000.00
SIBN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1350000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Inventory: 35534000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 214541000.00
SIBN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -6232000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Leases: 3873000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 6690000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 35599000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 42289000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 8531000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Net Debt: 2064000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Income: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4334000.00
SIBN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4334000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Interest Income: 758000.00
SIBN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -5155000.00
SIBN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 758000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Net PPE: 27781000.00
SIBN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1077000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 178942000.00
SIBN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2125000.00
SIBN income_statement (quarterly, 2026-03-31) — Normalized Income: -4334000.00
SIBN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2362000.00
SIBN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 332000.00
SIBN income_statement (quarterly, 2026-03-31) — Operating Income: -5093000.00
SIBN income_statement (quarterly, 2026-03-31) — Operating Revenue: 52588000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 44201473.00
SIBN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2942000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1013000.00
SIBN income_statement (quarterly, 2026-03-31) — Other Gand A: 10037000.00
SIBN income_statement (quarterly, 2026-03-31) — Other Income Expense: 1000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Other Inventories: 34000.00
SIBN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 119000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 217000.00
SIBN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Other Properties: 33866000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 111148000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Payables: 6761000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 11765000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8051000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
SIBN income_statement (quarterly, 2026-03-31) — Pretax Income: -4334000.00
SIBN cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 34000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SIBN cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 388000.00
SIBN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -51285000.00
SIBN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1077000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Receivables: 31561000.00
SIBN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 10644000.00
SIBN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1617000.00
SIBN income_statement (quarterly, 2026-03-31) — Research And Development: 4192000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -454592000.00
SIBN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 46130000.00
SIBN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 32808000.00
SIBN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 42845000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Share Issued: 44201473.00
SIBN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6025000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 178942000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 178942000.00
SIBN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SIBN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Assets: 242718000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 214541000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Debt: 42947000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 178942000.00
SIBN income_statement (quarterly, 2026-03-31) — Total Expenses: 57681000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 63776000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 27998000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 42289000.00
SIBN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -5093000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Work In Process: 3600000.00
SIBN balance_sheet (quarterly, 2026-03-31) — Working Capital: 193233000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -900500000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2944300000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -43500000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 39571684.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Basic EPS: -0.15
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 825200000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 58900000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 0.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 1900000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 4400000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 39571684.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Diluted EPS: -0.15
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 4400000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 820200000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 37700000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2505500000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Interest Income: 28300000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 28300000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Inventories Adjustments Allowances: 0.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 715400000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 2400000.00
SICAGEN.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -65600000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 724400000.00
SICAGEN.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -65600000.00
SICAGEN.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -65600000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 500000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4100000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 54500000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Other Special Charges: 65700000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16900000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 135200000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 172300000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 7700000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 7700000.00
SICAGEN.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -65600000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 7300000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -519200000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 54200000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 91900000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 6500000.00
SICAGEN.NS balance_sheet (annual, 2022-03-31) — Work In Process: 43600000.00
SICAGEN.NS income_statement (annual, 2022-03-31) — Write Off: 10500000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — +Operating Expense: 636300000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — +Total Revenue: 8898500000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 534500000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1870300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1018400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2944300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -67400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 12000000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 720900000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 39571684.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Basic EPS: 4.50
SICAGEN.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 58900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 858400000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -52700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 140800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 395700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 31600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 217200000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -9900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 31600000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -409800000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 79000000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Change In Payable: -450900000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 569500000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -212200000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -27300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Common Stock: 395700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4395600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 8099100000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4124600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 31800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1071600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1103400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 1800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1730900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 15700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 3900000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Depreciation: 105400000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 105400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 105400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 105400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 39571684.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Diluted EPS: 4.50
SICAGEN.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 178200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 3700000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 3100000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — EBIT: 299000000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — EBITDA: 404400000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — End Cash Position: 31600000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -134500000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 1212200000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 95900000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -90600000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -9900000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 43200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 2800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1937700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2387200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Gross Profit: 799400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Interest Expense: 82600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 82600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Interest Income: 46500000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 46500000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -82600000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 48900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Inventories Adjustments Allowances: -200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Inventory: 1445900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 5467200000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -41400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 43600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 720900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 689700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 109000000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 109000000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -2400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 3700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 824300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1040000000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 80600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Income: 178200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 178200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 178200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 178200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 178200000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 216400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 178200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Interest Income: -42300000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -54100000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -2400000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -2400000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -42300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Net PPE: 1368800000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -39300000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 0.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4392800000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 50700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 32100000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 328500000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Normalized Income: 115698243.99
SICAGEN.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 148600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Operating Income: 163100000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Operating Revenue: 8898500000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 39571684.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 42100000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 17500000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 3999900000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 2800000.00
SICAGEN.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 36100000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 30200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 2700000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 16900000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 237300000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Properties: 13600000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 360100000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 185600000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Other Special Charges: -10500000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Payables: 538200000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15700000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 44200000.00
SICAGEN.NS income_statement (annual, 2023-03-31) — Pretax Income: 216400000.00
SICAGEN.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00